Dextromethorphan for Tardive Dyskinesia
Jungjin Kim, James Donovan, Thomas L. Schwartz
International Neuropsychiatric Disease Journal · pp. 136–140 · Published 11 Feb 2014
10.9734/INDJ/2014/7970Abstract
Aims: To report three cases of successful treatment of tardive dyskinesia (TD) with dextromethorphan. Study Design: Retrospective chart review. Place and Duration of Study: Private outpatient practice in Syracuse, NY. Methodology: A retrospective chart review of patients with TD who were treated with dextromethorphan between 2003 and 2013 was conducted. Results: Three consecutive patients experienced marked improvement of TD with dextromethorphan. Conclusion: Dextromethorphan may be a useful drug for treating TD. Further prospective studies are needed.
References (15)
- 1 Oxidative Mechanisms and Tardive Dyskinesia [DOI]
- 2 Dextromethorphan An Overview of Safety Issues [DOI]
- 3 Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation [DOI]
- 4 Review of Pseudobulbar Affect Including a Novel and Potential Therapy [DOI]
- 5 Role of Opioidergic and Serotonergic Mechanisms in Cough and Antitussives [DOI]
- 6 High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens [DOI]
- 7 A trial of dextromethorphan in parkinsonian patients with motor response complications [DOI]
- 8 Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan [DOI]
- 9 Anti‐dyskinetic mechanisms of amantadine and dextromethorphan in the 6‐OHDA rat model of Parkinson’s disease: role of NMDA vs. 5‐HT1A receptors [DOI]
- 10 Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N- in brain slices [DOI]
- 11 Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease [DOI]
- 12 Free radical mechanisms in schizophrenia and tardive dyskinesia [DOI]
- 13 Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats.
- 14 Excitotoxic Mechanisms May Be Involved in the Pathophysiology of Tardive Dyskinesia [DOI]
- 15 Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex [DOI]
Cited by 3
Anna Maria Szota, Jørgen Scheel-Krüger · Behavioural Pharmacology · 2020
Showing 1 of 3 known citations — external sources report more than can currently be individually listed.
Related research
- Effect of Vernonia Amygdalina Leaf on Cytochrome P450 2D6- and 3A4-Mediated Metabolism of Dextromethorphan in Healthy Nigerian Subjects — shares topic coverage
- Anti-Inflammatory and Antitussive Activity of Asthpadose, a Phytomedicine used in the Treatment of Asthma in Côte d'Ivoire — shares topic coverage
- Effect of Chronic Oral Exposure to Overdose of Cough Syrups on Rate of DNA Fragmentation in Liver and Brain of Wistar Rats — shares topic coverage
- Dextromethorphan Use in the Outpatient Department — shares topic coverage
- Development and Validation of a Method for Simultaneous Estimation of Bupropion and Dextromethorphan Using Reverse Phase High Performance Liquid Chromatography in Active Pharmaceutical Ingredient Form — shares topic coverage
Article metrics
Real usage data collected on this platform.
22
Page views
0
PDF downloads
2
Outbound clicks
3
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.